SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?


To: Jongmans who wrote (56)11/7/2000 4:43:49 AM
From: nigel bates  Read Replies (1) | Respond to of 469
 
Isn't it more of a revision than a continuation -
Under the terms of the revised agreement, the companies will move from an exclusive profit sharing arrangement to a non-exclusive contract payment basis. Incyte will retain the sole rights to market LifeExpress and OGS will continue to provide Incyte and subscribers with data on an ongoing basis.
Sound better for INCY than OGS.

nig